valsartan has been researched along with Retinal Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyake, S; Nagai, N; Narimatsu, T; Ozawa, Y; Tsubota, K | 1 |
| DeKosky, ST; Feldman, AM; Haller, JA | 1 |
| Downie, LE; Fletcher, EL; Pianta, MJ; Vingrys, AJ; Wilkinson-Berka, JL | 1 |
3 other study(ies) available for valsartan and Retinal Degeneration
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blockade suppresses light-induced neural damage in the mouse retina.
Topics: Acetylcysteine; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Apoptosis; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Fas Ligand Protein; Gene Expression Regulation; Light; Losartan; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-fos; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retinal Degeneration; Retinal Photoreceptor Cell Outer Segment; Signal Transduction; Tetrazoles; Valine; Valsartan | 2014 |
Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations.
Topics: Alzheimer Disease; Aminobutyrates; Amyloid beta-Peptides; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Brain; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haplorhini; Heart Failure; Humans; Mice; Neprilysin; Retinal Degeneration; Tetrazoles; Valsartan | 2016 |
AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Astrocytes; Neovascularization, Physiologic; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Degeneration; Retinal Vessels; Tetrazoles; Valine; Valsartan | 2008 |